Danaher | DHR - Себестоимость

Биржевая цена
178.80
Изменение за день
-0.18 -0.10%
Ежемесячно
-2.77%
Ежегодный
-10.30%
Q2 прогноз
173.46




Себестоимость Изменить Дата
Abbott USD 5.3B 380M 2026-03
Agilent USD 852M 19M 2025-12
Align Technology USD 363.97M 7.48M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Bio Techne USD 104.6M 6.16M 2025-12
Bio-Rad Laboratories USD 309.6M 3.3M 2025-09
Boston Scientific USD 1.83B 8M 2026-03
Bruker USD 528M 46.9M 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Danaher USD 2.36B 512M 2026-03
Dentsply International USD 518M 55M 2025-12
Edwards Lifesciences USD 362.6M 19.6M 2026-03
ESCO Technologies USD 190.06M 13.17M 2025-12
Fortive USD 413.6M 35.7M 2025-12
Henry Schein USD 2.44B 62M 2025-12
Illumina USD 400M 49M 2025-12
Intuitive Surgical USD 940.3M 21.6M 2026-03
IQVIA Holdings USD 3.24B 518M 2025-12
Keysight Technologies USD 605M 55M 2025-12
Laboratory Of America USD 2.6B 56.8M 2025-12
Medtronic USD 3.61B 83M 2025-12
Mettler Toledo International USD 473.97M 33.71M 2025-12
Myriad Genetics USD 63M 1.1M 2025-12
OraSure Technologies USD 15.43M 113K 2025-12
Quest Diagnostics USD 1.99B 57M 2026-03
Quidel USD 448.8M 1.21B 2025-12
Repligen USD 94.08M 5.79M 2025-12
Revvity USD 350.4M 26.05M 2025-12
Roper Industries USD 641.5M 12.8M 2026-03
Stryker USD 2.69B 373M 2025-12
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Waters USD 374.94M 47.13M 2025-12
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03